It acts by activating the extracellular signal-regulated kinase (ERK) and reducing the Bim level, leading to cardiac repair effects in infarcted hearts.[41] There is limited research on the relationship between NT-3 and CHD, and our MR studies indicate that genetically predicted NT-3 is involved in the development of CHD. The gene discussed is BCL2L11; the disease is coronary artery disorder.